Total Payments
$1,133
2024 Payments
$1,043
Companies
13
Transactions
49
Medicare Patients
149
Medicare Billing
$20,585
Payment Breakdown by Category
Food & Beverage$1,133 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,133 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $233.28 | 8 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $218.66 | 11 | $0 (2024) |
| ABBVIE INC. | $176.80 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $130.28 | 6 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $60.18 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $55.69 | 3 | $0 (2024) |
| Alkermes, Inc. | $54.93 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $54.38 | 3 | $0 (2024) |
| Indivior Inc. | $53.94 | 2 | $0 (2024) |
| Lundbeck LLC | $36.25 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,043 | 45 | Neurocrine Biosciences, Inc. ($233.28) |
| 2023 | $90.88 | 4 | Janssen Pharmaceuticals, Inc ($24.70) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.67 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.59 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: CNS | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Neurology | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $39.45 | General |
| Category: Neuropsychiatry | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Neurology | ||||||
| 09/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Neuroscience | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $43.27 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neuroscience | ||||||
| 08/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Neurology | ||||||
| 08/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 36 | 50 | $8,835 | $2,885 |
| 2022 | 2 | 69 | 235 | $35,090 | $13,998 |
| 2021 | 2 | 44 | 51 | $6,155 | $3,701 |
Total Patients
149
Total Services
336
Medicare Billing
$20,585
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 32 | $5,775 | $2,140 | 37.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 15 | 18 | $3,060 | $745.51 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 156 | $23,750 | $9,377 | 39.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 25 | 79 | $11,340 | $4,622 | 40.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 29 | $3,625 | $2,112 | 58.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 20 | 22 | $2,530 | $1,589 | 62.8% |
About Mona Daye, APN
Mona Daye, APN is a Psychiatric/Mental Health, Child & Adolescent healthcare provider based in Morris, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1619140316.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mona Daye, APN has received a total of $1,133 in payments from pharmaceutical and medical device companies, with $1,043 received in 2024. These payments were reported across 49 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,133).
As a Medicare-enrolled provider, Daye has provided services to 149 Medicare beneficiaries, totaling 336 services with total Medicare billing of $20,585. Data is available for 3 years (2021–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health, Child & Adolescent
- Other Specialties Child & Adolescent
- Location Morris, IL
- Active Since 04/02/2008
- Last Updated 12/21/2010
- Taxonomy Code 364SP0807X
- Entity Type Individual
- NPI Number 1619140316
Products in Payments
- INGREZZA (Drug) $233.28
- UZEDY (Drug) $203.51
- VRAYLAR (Drug) $176.80
- INVEGA SUSTENNA (Drug) $82.83
- Qelbree (Drug) $60.18
- ARISTADA (Drug) $54.93
- COBENFY (Drug) $54.38
- PERSERIS (Drug) $53.94
- SPRAVATO (Drug) $47.45
- CAPLYTA (Drug) $44.35
- ABILIFY MAINTENA (Drug) $41.45
- REXULTI (Drug) $36.25
- Austedo XR (Drug) $15.15
- JORNAY PM (Drug) $14.67
- ABILIFY ASIMTUFII (Drug) $14.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.